Canadian allergists/immunologists comment on recent Australian oral immunotherapy study

AllerGen investigators Drs Manel Jordana and Susan Waserman and AllerGen HQP Dr. Derek Chu have prepared a statement in response to a recent Australian study being heralded as a “breakthrough” and a “cure” for peanut allergy.

The paper, published in an August 2017 issue of The Lancet Child & Adolescent Health, assessed outcomes in participants who completed a trial of probiotic and peanut oral immunotherapy (PPOIT) four years prior. Results from the original PPOIT trial were published in 2015 in The Journal of Allergy and Clinical Immunology.

Drs Jordana, Waserman and Chu welcome comments and feedback on their statement from stakeholders in the allergy community.

Drs Jordana/Waserman/Chu’s statement: Peanut allergy immunotherapy—what are the facts?

The Lancet Child & Adolescent Health publication (August 15, 2017)

The Journal of Allergy and Clinical Immunology publication (January 13, 2015)